Benign breast lesions at risk of developing cancer - A challenging problem in breast cancer screening programs: Five years' experience of the breast cancer screening program in Verona (1999-2004)

Cancer

Volumn 115, Issue 3, 2009, Pages 499-507

  Manfrin, Erminia ^a   Mariotto, Renata ^b   Remo, Andrea ^a   Reghellin, Daniela ^a   Falsirollo, Francesca ^c   Dalfior, Daniela ^a   Bricolo, Paola ^c   Piazzola, Elena ^a   Bonetti, Franco ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b CARLO POMA HOSPITAL   (Italy)

^c Marzana Hospital   (Italy)

Author keywords

Benign breast lesions; Breast cancer screening program; Fine needle aspiration cytology; Lesions at risk of developing cancer; Needle biopsy

Indexed keywords

ADULT; AGED; ARTICLE; ATYPICAL COLUMNAR CELL HYPERPLASIA; ATYPICAL DUCTAL HYPERPLASIA; ATYPICAL LOBULAR HYPERPLASIA; BENIGN TUMOR; BREAST ADENOSIS; BREAST BIOPSY; BREAST CANCER; BREAST FIBROADENOMA; BREAST HYPERPLASIA; BREAST PAPILLOMA; BREAST TUMOR; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CYSTOSARCOMA PHYLLOIDES; FEMALE; FIBROCYSTIC BREAST DISEASE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MASTITIS; PAPILLOMATOSIS; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS;

AGED; BIOPSY; BIOPSY, NEEDLE; BREAST DISEASES; BREAST NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MASS SCREENING; MIDDLE AGED; RISK;

EID: 60049090813     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24038     Document Type: Article

References (53)

1. Foote FW, Stewart FW. Comparative studies of cancerous versus noncancerous breasts. Ann Surg. 1945;121:197-222.
2. Wellings SR, Jensen HM. On the origin and progression of ductal carcinoma in the human breast. J Natl Cancer Inst. 1973;50:1111-1118.
3. Wellings SR, Jensen HM, Marcum RG. An atlas of sub-gross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst. 1975;55:231-273.
4. Page DL, Dupont WD, Rogers LW, Landemberger M. Intraductal carcinoma of the breast: follow-up after biopsy only. Cancer. 1982;49:751-758.
5. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312:146-151.
6. Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55:2698-2708.
7. Palli D, Rosselli del Turco M, Simoncini R, Bianchi S. Benign breast disease and breast cancer: a case-control study in a cohort in Italy. Int JCancer. 1991;47:703-706.
8. London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA. 1992;267:941-944.
9. Bodian CA, Perzin KH, Lattes R, Hoffmann P, Abernathy TG. Prognostic significance of benign proliferative breast disease. Cancer. 1993;71:3896-3907.
10. Page DL. The woman at high risk for breast cancer. Importance of hyperplasia. Surg Clin North Am. 1996;76:221-230.
11. Fitzgibbons PL, Henson DE, Hutter RV. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med. 1998;122:1053-1055.
12. Page DL, Dupont WD. Benign breast diseases and premalignant breast disease. Arch Pathol Lab Med. 1998;122:1048-1050.
13. Allred DC, Mohsin SK, Fuqua SA. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer. 2001;8:47-61.
14. Shaaban AM, Sloane JP, West CR, et al. Histopathologic types of benign breast lesions and the risk of breast cancer: case-control study. Am J Surg Pathol. 2002;26:421-430.
15. Schnitt SJ. Benign breast disease and breast cancer risk: morphology and beyond. Am J Surg Pathol. 2003;27:836-841.
16. Sewell CW. Pathology of high-risk breast lesions and ductal carcinoma in situ. Radiol Clin North Am. 2004;42:821-830.
17. Hartmann LC, Sellers TA, Frost MH, et al. Benign breast disease and the risk of breast cancer. N Engl J Med. 2005;353:229-237.
18. Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol. 1995;164:1111-1113.
19. Gadzala DE, Cederbom GJ, Bolton JS, et al. Appropriate management of atypical ductal hyperplasia diagnosed by stereotactic core needle breast biopsy. Ann Surg Oncol. 1997;4:283-286.
20. Darling ML, Smith DN, Lester SC, et al. Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: results of surgical excision. AJR Am J Roentgenol. 2000;175:1341-1346.
21. Harvey JM, Sterrett GF, Frost FA. Atypical ductal hyper- plasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis. Pathology. 2002;34:410-416.
22. Jacobs TW, Connolly JL, Schnitt SJ. Nonmalignant lesions in breast core needle biopsies: to excise or not to excise? Am J Surg Pathol. 2002;26:1095-1110.
23. Schnitt SJ. The diagnosis and management of preinvasive breast disease: flat epithelial atypia classification, pathologic features and clinical significance. Breast Cancer Res. 2003;5:263-268.
24. Elsheikh TM, Silverman JF. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol. 2005;29:534-543.
25. Carder PJ, Liston JC. Will the spectrum of lesions prompting a "B3" breast core biopsy increase the benign biopsy rate? J Clin Pathol. 2003;56:133-138.
26. Lee AH, Denley HE, Pinder SE, et al. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology. 2003; 42:331-336.
27. Liberman L, Tornos C, Huzjan R, Bartella L, Morris EA, Dershaw DD. Is surgical excision warranted after benign, concordant diagnosis of papilloma at percutaneous breast biopsy? AJR Am J Roentgenol. 2006;186:1328-1334.
28. Ciatto S, Houssami N, Ambrogetti D, et al. Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat. 2007;101:291-297.
29. Houssami N, Ciatto S, Ellis I, Ambrogetti D. Understimation of malignancy of the breast core-needle biopsy: concepts and precise overall and category-specific estimates. Cancer. 2007;109:487-495.
30. Perry N, Broeders M, de Wolf C, Tornemberg S, Holland R, von Karsa L. European Guidelines for Quality Assurance in Breast Cancer Screening and Diagnosis. 4th ed. Luxembourg: Office for Official Publications of the European Communities; 2006.
31. Spencer NJ, Evans AJ, Galea M, et al. Pathological-radiological correlations in benign lesions excised during a breast screening programme. Clin Radiol. 1994;49:853-856.
32. Burnett SJ, Ng YY, Perry NM, et al. Benign biopsies in the prevalent round of breast screening: a review of 137 cases. Clin Radiol. 1995;50:254-258.
33. Maxwell AJ, Pearson JM, Bishop HM. Crude open biopsy rates for benign screen detected lesions no longer reflect breast screening quality - time to change the standard. J Med Screen. 2002;9:83-85.
34. Fabbri S, Perfetti E, Govoni D, Bianchi S, Brancato B, Paci E; GISMA Working Group. Benign breast diseases in breast cancer screening programs in Italy (2000-2001). Tumori. 2004;90:547-549.
35. Mariotto R, Brancato B, Bonetti F, et al. Real-time reading in mammography breast screening. Radiol Med. 2007;112:287-303.
36. Manfrin E, Mariotto R, Remo A, et al. Is there still a role for fine-needle aspiration cytology in breast cancer screening? Experience of the Verona mammographic breast cancer screening program with real-time integrated radiopathologic activity (1999-2004). Cancer. 2009;114:74-82.
37. Tavassoli FA, Devilee P. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003.
38. Giorgi D, Giordano L, Ventura L, Frigerio F, Paci E, Zappa M. Mammographic screening in Italy, 2005. In: Scarl I, ed. Six National Surveys on Italian Screening Programs. Milan, Italy: Inferenze Scarl; 2005:20-35.
39. Adrales G, Turk P, Wallace T, Bird R, Norton HJ, Green F. Is surgical excision necessary for atypical ductal hyperplasia of the breast diagnosed by Mammotome? Am J Surg. 2000;180:313-315.
40. Sneige N, Lim SC, Whitman GJ, et al. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereo- tactic biopsy of breast microcalcifications. Consideration for surgical excision. Am J Clin Pathol. 2003;119:248-253.
41. Renshaw AA, Cartagena N, Schenkman RH, Derhagopian RP, Gould EW. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies. Am J Clin Pathol. 2001;116:92-96.
42. Rosen PP. Benign papillary tumors. In: Rosen PP, ed. Rosen's Breast Pathology. Philadelphia, Pa: Lippincott- Raven; 1997:67-104.
43. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2009;52:20-29.
44. Sloane JP, Mayers MM. Carcinoma and atypical hyperplasia in radial scars and complex sclerosing lesions: importance of lesion size and patient age. Histopathology. 1993; 23:225-231.
45. Manfrin E, Remo A, Falsirollo F, Reghellin D, Bonetti F. Risk of neoplastic transformation in asymptomatic radial scar. Analysis of117 cases. Breast Cancer Res Treat. 2009; 107:371-377.
46. Lee AH. Recent developments in the histological diagnosis of spindle cell carcinoma, fibromatosis and phyllodes tumor of the breast. Histopathology. 2009;52:45-57.
47. Rosen PP. Mucocele-like tumors of the breast. Am J Surg Pathol. 1986;10:464-469.
48. Chinyama CN, Davies JD. Mammary mucinous lesions: congeners, prevalence and important pathological associations. Histopathology. 1996;29:533-539.
49. Tan PH, Tse GM, Bay BH. Mucinous breast lesions: diagnostic challenges. J Clin Pathol. 2009;61:11-19.
50. Schnitt SJ, Vincent-Salomon A. Columnar cell lesions of the breast. Adv Anat Pathol. 2003;10:113-124.
51. Feeley L, Quinn CM. Columnar cell lesions of the breast. Histopathology. 2009;52:11-19.
52. Chew I, Tan Y, Tan PH. Cytology is useful in breast screening: results and long-term follow-up of the Singapore breast screening pilot project. Cytopathology. 2006;17:227-232.
53. Farshid G, Downey P, Gill PG, Pieterse S. Assessment of 1183 screen-detected, category 3B, circumscribed masses by cytology and core biopsy with long-term follow up data. Br J Cancer. 2009;98:1182-1190.